Leppä S - Search Results

1

Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.

Holte H, Leppä S, Björkholm M, Fluge O, Jyrkkiö S, Delabie J, Sundström C, Karjalainen-Lindsberg ML, Erlanson M, Kolstad A, Fosså A, Ostenstad B, Löfvenberg E, Nordström M, Janes R, Pedersen LM, Anderson H, Jerkeman M, Eriksson M. Holte H, et al. Among authors: leppa s. Ann Oncol. 2013 May;24(5):1385-92. doi: 10.1093/annonc/mds621. Epub 2012 Dec 17. Ann Oncol. 2013. PMID: 23247661 Free article. Clinical Trial.

2

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model.

Monzo HJ, Kalander K, Hyytiäinen MM, Elbasani E, Wall J, Moyano-Galceran L, Tanjore Ramanathan J, Jukonen J, Laakkonen P, Ristimäki A, Carlson JW, Lehti K, Salehi S, Puolakkainen P, Haglund C, Seppänen H, Leppä S, Ojala PM. Monzo HJ, et al. Among authors: leppa s. Mol Cancer Ther. 2023 Nov 1;22(11):1319-1331. doi: 10.1158/1535-7163.MCT-23-0008. Mol Cancer Ther. 2023. PMID: 37486980

3

Mitogen-activated protein kinases and activator protein 1 are required for proliferation and cardiomyocyte differentiation of P19 embryonal carcinoma cells.

Eriksson M, Leppä S. Eriksson M, et al. Among authors: leppa s. J Biol Chem. 2002 May 3;277(18):15992-6001. doi: 10.1074/jbc.M107340200. Epub 2002 Mar 7. J Biol Chem. 2002. PMID: 11884386 Free article.

4

ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.

Jerkeman M, Leppä S, Kvaløy S, Holte H. Jerkeman M, et al. Among authors: leppa s. Eur J Haematol. 2004 Sep;73(3):179-82. doi: 10.1111/j.1600-0609.2004.00294.x. Eur J Haematol. 2004. PMID: 15287915 Clinical Trial.

5

Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.

Eriksson M, Taskinen M, Leppä S. Eriksson M, et al. Among authors: leppa s. J Cell Physiol. 2007 Feb;210(2):538-48. doi: 10.1002/jcp.20907. J Cell Physiol. 2007. PMID: 17111371

6

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

Nyman H, Adde M, Karjalainen-Lindsberg ML, Taskinen M, Berglund M, Amini RM, Blomqvist C, Enblad G, Leppä S. Nyman H, et al. Among authors: leppa s. Blood. 2007 Jun 1;109(11):4930-5. doi: 10.1182/blood-2006-09-047068. Epub 2007 Feb 13. Blood. 2007. PMID: 17299093 Free article.

7

A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.

Taskinen M, Karjalainen-Lindsberg ML, Nyman H, Eerola LM, Leppä S. Taskinen M, et al. Among authors: leppa s. Clin Cancer Res. 2007 Oct 1;13(19):5784-9. doi: 10.1158/1078-0432.CCR-07-0778. Clin Cancer Res. 2007. PMID: 17908969

8

Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

Taskinen M, Karjalainen-Lindsberg ML, Leppä S. Taskinen M, et al. Among authors: leppa s. Blood. 2008 May 1;111(9):4664-7. doi: 10.1182/blood-2007-11-125823. Epub 2008 Feb 28. Blood. 2008. PMID: 18309035 Free article. Clinical Trial.

9

Impact of germinal center and non-germinal center phenotypes on overall and failure-free survival after high-dose chemotherapy and auto-SCT in primary diffuse large B-cell lymphoma.

Nyman H, Jantunen E, Juvonen E, Elonen E, Böhm J, Kosma VM, Enblad G, Karjalainen-Lindsberg ML, Leppä S. Nyman H, et al. Among authors: leppa s. Bone Marrow Transplant. 2008 Jul;42(2):93-8. doi: 10.1038/bmt.2008.92. Epub 2008 Apr 7. Bone Marrow Transplant. 2008. PMID: 18391989

10

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.

Nyman H, Jerkeman M, Karjalainen-Lindsberg ML, Banham AH, Enblad G, Leppä S. Nyman H, et al. Among authors: leppa s. Eur J Haematol. 2009 May;82(5):364-72. doi: 10.1111/j.1600-0609.2009.01222.x. Epub 2009 Jan 9. Eur J Haematol. 2009. PMID: 19141121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page